Overview
ISO 11135:2014 - Sterilization of health‑care products - Ethylene oxide specifies the requirements for the development, validation and routine control of an ethylene oxide (EO) sterilization process for medical devices. It covers both industrial and health‑care facility settings and recognises their similarities and differences. The standard describes a structured program - from sterilizing‑agent characterization through equipment and process qualification to routine monitoring and product release - intended to provide a high degree of confidence in achieving sterile medical products.
Key topics and technical requirements
ISO 11135:2014 focuses on practical, auditable requirements (normative) and supporting guidance (informative annexes). Major technical topics include:
- Sterilizing agent characterization
- EO properties, microbicidal effectiveness, material interactions, and safety/environmental considerations.
- Process and equipment characterization
- Definition of process parameters and mapping of equipment performance and limitations.
- Product definition and microbiological considerations
- Product physical and microbiological attributes that affect sterilization outcomes.
- Process definition and validation
- Validation lifecycle: Installation Qualification (IQ), Operational Qualification (OQ) and Performance Qualification (PQ).
- Validation approaches described in Annex A (biological indicator/bioburden), Annex B (overkill), and guidance in Annex D.
- Routine monitoring, control and product release
- Ongoing process control, documentation, and criteria for releasing sterilized lots (including Annex E on single lot release).
- Maintaining process effectiveness
- Equipment maintenance, requalification, change control and equivalence assessment.
- Measurement, documentation and quality management
- Integration with quality systems, documentation, and control of nonconforming product.
Practical applications and who uses it
ISO 11135:2014 is used by:
- Medical device manufacturers designing EO sterilization processes for new or existing devices.
- Contract sterilization service providers and industrial sterilizers operating EO chambers.
- Hospital sterile processing departments and health‑care facilities reprocessing reusable medical devices in accordance with manufacturer instructions.
- Regulatory and quality assurance professionals developing validation protocols, batch release criteria and change control procedures.
- Engineers and microbiologists performing IQ/OQ/PQ studies, biological indicator testing and routine process monitoring.
Practical benefits include consistent validation methodology, reduced regulatory risk, and improved patient safety through controlled EO exposure and residue considerations.
Related standards
- ISO 13485 - Quality management for medical devices
- ISO 9001 - Quality management systems
- ISO 10993‑7 - Biological evaluation (EO and by‑products)
- EN 556‑1 and ANSI/AAMI ST67 - Sterility assurance/sterilization requirements
Keywords: ISO 11135:2014, ethylene oxide sterilization, EO sterilization, medical device sterilization, sterilization validation, IQ OQ PQ, routine monitoring, sterilization process.
Open preview (PDF)Sterilization of health-care products — Ethylene oxide — Requirements for the development, validation and routine control of a sterilization process for medical devices